|
|
|
|
GMMMG Consultations |
|
|
On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below. |
|
|
Title |
Information |
Feedback |
End date |
|
|
71 |
A ustekinumab Crohns disease commissioning statement is available for consultation. We now seek comments on this document. This consultation period is open until 5pm Wednesday 27th November. |
5pm Wednesday |
||
|
70 |
A liothyronine injection commissioning statement is available for consultation. We now seek comments on this document. This consultation period is open until 5pm Wednesday 27th November. |
5pm Wednesday |
||
|
69 |
PaGDSG Shared Care Protocol for Penicillamine for Rheumatoid Arthritis or Wilsons disease in Adults |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Penicillamine for Rheumatoid Arthritis or Wilsons disease in Adults is in development. We now seek comments on this draft. This consultation period is open until 5pm Wednesday 27th November. |
5pm Wednesday |
|
|
68 |
Revised GMMMG pathway for High Cost Drugs for Treatment of Psoriasis in Adults |
With the support of the GMMMG High Cost Drugs Subgroups, a revised GMMMG pathway for High Cost Drugs for Treatment of Psoriasis in Adults has been developed and is now open for comment. The draft pathway plus consultation notes are available through this consultation which runs until 5pm Wednesday 13th November. Following consultation and consideration of the comments received GMMMG will finalise a pathway to be recommended to GM Directors of Commissioning for GM wide implementation, therefore all comments are welcomed. The consultation is open until 5pm Wednesday 13th November. |
5pm Wednesday |
|
|
67 |
The following FMESG actions for September 2019 have been proposed and will be sent to CSB for support. We now seek comments on these proposals. This consultation is open until 5pm on Tuesday 12th November. |
5pm Tuesday 12th November 2019 |
||
|
66 |
PaGDSG Shared Care Protocol for First generation (Typical) antipsychotic depots in adults |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for First generation (Typical) antipsychotic depots in adults is in development. We now seek comments on this draft. This consultation period is open until 5pm Tuesday 22nd October. |
5pm Tuesday |
|
|
65 |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Riluzole for ALS is in development. We now seek comments on this draft. This consultation period is open until 5pm Tuesday 22nd October. |
5pm Tuesday |
||
|
64 |
The following FMESG actions for August 2019 have been proposed and will be sent to CSB for support. We now seek comments on these proposals. This consultation is open until 5pm on Monday 21st October 2019 |
5pm Monday |
||
<< Back
